全文获取类型
收费全文 | 38925篇 |
免费 | 2268篇 |
国内免费 | 182篇 |
专业分类
耳鼻咽喉 | 406篇 |
儿科学 | 882篇 |
妇产科学 | 987篇 |
基础医学 | 5929篇 |
口腔科学 | 2553篇 |
临床医学 | 3154篇 |
内科学 | 8411篇 |
皮肤病学 | 1167篇 |
神经病学 | 3375篇 |
特种医学 | 680篇 |
外科学 | 3156篇 |
综合类 | 154篇 |
一般理论 | 21篇 |
预防医学 | 4416篇 |
眼科学 | 594篇 |
药学 | 3089篇 |
中国医学 | 250篇 |
肿瘤学 | 2151篇 |
出版年
2024年 | 49篇 |
2023年 | 444篇 |
2022年 | 1007篇 |
2021年 | 1761篇 |
2020年 | 1014篇 |
2019年 | 1449篇 |
2018年 | 1774篇 |
2017年 | 1187篇 |
2016年 | 1150篇 |
2015年 | 1413篇 |
2014年 | 1888篇 |
2013年 | 2297篇 |
2012年 | 3480篇 |
2011年 | 3703篇 |
2010年 | 1847篇 |
2009年 | 1535篇 |
2008年 | 2544篇 |
2007年 | 2536篇 |
2006年 | 2146篇 |
2005年 | 1950篇 |
2004年 | 1689篇 |
2003年 | 1430篇 |
2002年 | 1208篇 |
2001年 | 226篇 |
2000年 | 189篇 |
1999年 | 206篇 |
1998年 | 182篇 |
1997年 | 162篇 |
1996年 | 103篇 |
1995年 | 86篇 |
1994年 | 83篇 |
1993年 | 63篇 |
1992年 | 97篇 |
1991年 | 66篇 |
1990年 | 61篇 |
1989年 | 43篇 |
1988年 | 40篇 |
1987年 | 23篇 |
1986年 | 23篇 |
1985年 | 25篇 |
1984年 | 19篇 |
1983年 | 15篇 |
1982年 | 23篇 |
1981年 | 14篇 |
1980年 | 17篇 |
1979年 | 15篇 |
1976年 | 8篇 |
1975年 | 10篇 |
1974年 | 9篇 |
1973年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Judith S. Nijmeijer Alejandro Arias-Vásquez Nanda N.J. Rommelse Marieke E. Altink Richard J.L. Anney Philip Asherson Tobias Banaschewski Cathelijne J.M. Buschgens Ellen A. Fliers Michael Gill Ruud B. Minderaa Luise Poustka Joseph A. Sergeant Jan K. Buitelaar Barbara Franke Richard P. Ebstein Ana Miranda Fernando Mulas Robert D. Oades Herbert Roeyers Pieter J. Hoekstra 《Journal of the American Academy of Child and Adolescent Psychiatry》2010,49(7):675-685
992.
The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice 总被引:1,自引:0,他引:1
Juan Perucho Isabel Rubio Ana Gómez Izaskun Rodal Eva Carro Maria A. Mena 《Experimental neurology》2010,221(1):54-67
Parkin suppression induces accumulation of β-amyloid in mutant tau mice. We studied the effect of parkin suppression on behaviour and brain pathology in APPswe mutant mice. We produced double mutant mice with human mutated APPswe + partial (hemizygote) or total (homozygote) deletion of Park-2 gene. We studied the development, behaviour, brain histology, and biochemistry of 12- and 16-month-old animals in 6 groups of mice, with identical genetic background: wild-type (WT), APPswe overexpressing (APP), hemizygote and homozygote deletion of Park-2 (PK+/− and PK−/−, respectively), and double mutants (APP/PK+/− and APP/PK−/−).APP mice have reduced weight gain, decreased motor activity, and reduced number of entrances and of arm alternation in the Y-maze, abnormalities which were partially or completely normalized in APP/PK+/− and APP/PK−/− mice. The double mutants had similar number of mutant human APP transgene copies than the APP and levels of 40 and 80 kDa proteins; but both of them, APP/PK+/− and APP/PK−/− mice, had less plaques in cortex and hippocampus than the APP mice. APP mutant mice had increased apoptosis, proapoptotic Bax/Bcl2 ratios, and gliosis, but these death-promoting factors were normalized in APP/PK+/− and APP/PK−/− mice. APP mutant mice had an increased number of tau immunoreactive neuritic plaques in the cerebral cortex as well as increased levels of total and phosphorylated tau protein, and these changes were partially normalized in APP/PK+/− heterozygotic and homozygotic APP/PK−/− mice. Compensatory protein-degrading systems such as HSP70, CHIP, and macroautophagy were increased in APP/PK+/− and APP/PK−/−. Furthermore, the chymotrypsin- and trypsin-like proteasome activities, decreased in APP mice in comparison with WT, were normalized in the APP/PK−/− mice.We proposed that partial and total suppression of parkin triggers compensatory mechanisms, such as chaperone overexpression and increased autophagy, which improved the behavioural and cellular phenotype of APPswe mice. 相似文献
993.
994.
Ringer Ariana Ruffino Juan Pablo Leiva Rodolfo Cuadranti Nadia Argento María Cecilia Martínez María Florencia Rolla Ignacio Chulibert Serenela Carbone Daniela Palatnik Mariano Cortese Maria Noel Lagrutta Mariana Córdoba Laura González Florencia Belén Pacini María Florencia Villar Silvina Raquel Águila Damian Bottasso Oscar Adelmo Pérez Ana Rosa Abdala Marcelo 《Clinical rheumatology》2021,40(7):2955-2963
Clinical Rheumatology - Evidence for Chagas disease reactivation (CDR) in rheumatologic patients under rheumatologic treatments (RTs) is scarce. To screen and follow-up patients with rheumatic... 相似文献
995.
de Paula Reis Michelle de Lima Daniely Alves Pauli Karoline Bach Andreotti Carlos Eduardo Linhares de Moraes André Luiz Soares Gonçalves Daniela Dib Navarro Italmar Teodorico Bueno Paulo Sérgio Alves Seixas Flavio Augusto Vicente Gasparotto Junior Arquimedes Lourenço Emerson Luiz Botelho 《Parasitology research》2018,117(5):1465-1471
Parasitology Research - Toxoplasmosis is a zoonosis of worldwide distribution. Currently, two drugs, pyrimethamine and sulfadiazine, are used as a reference in the treatment of toxoplasmosis, but... 相似文献
996.
Pérez-Sánchez R Valero ML Ramajo-Hernández A Siles-Lucas M Ramajo-Martín V Oleaga A 《Molecular and biochemical parasitology》2008,161(2):112-123
Schistosoma bovis, a parasite of ruminants, can live for years in the bloodstream in spite of the immune response of its host. The parasite tegument covers the entire surface of the worm and plays a key role in the host-parasite relationship. The parasite molecules involved in host immune response evasion mechanisms must be expressed on the tegument surface and are potential targets for immune or drug intervention. The purpose of the present work was to identify the tegumental proteomes of male and female S. bovis worms, in particular the proteins expressed on the outermost layers of the tegument structure. Adult worms of each sex were treated separately with trypsin in order to digest their tegumental proteins, after which the peptides released were analysed by LC-MS/MS for identification. This experimental approach afforded valuable information about the protein composition of the tegument of adult S. bovis worms. A range of tegumental proteins was identified, most of which had not been identified previously in this species. Although an absolute purification of the proteins expressed on the outermost layers of the tegument structure was not achieved, it is likely that present among the proteins identified are some of the molecules most closely associated with the tegument surface. Our study also suggests that there may be differences in the protein composition of the tegument of male and female schistosomes. Finally, the presence of actin and GAPDH on the surface of male and female worms and the presence of enolase exclusively on the surface of male worms were verified by confocal microscopy. 相似文献
997.
Brahimi F Matheson SL Dudouit F McNamee JP Tari AM Jean-Claude BJ 《The Journal of pharmacology and experimental therapeutics》2002,303(1):238-246
The Combi-Targeting concept postulates that a molecule termed combi-molecule (C-molecule) with binary epidermal growth factor receptor (EGFR) targeting/DNA-damaging properties and with the ability to be hydrolyzed to another EGFR inhibitor should induce sustained antiproliferative activity in cells overexpressing EGFR. Because we postulate that the EGFR affinity of the C-molecule and that of its hydrolytic metabolites are critical parameters for sustained potency against EGFR-overexpressing cells, we synthesized BJ2000 (IC(50) = 0.1 microM, competitive binding at ATP site), a novel C-molecule that can decompose into a 6-amino-4-anilinoquinazoline FD105 (IC(50) = 0.2 microM). Studies using the EGFR-overexpressing A431 cells revealed that BJ2000 could damage DNA and block epidermal growth factor-stimulated EGFR autophosphorylation by a partially irreversible mechanism. Blockade of EGFR autophosphorylation subsequently induced inhibition of mitogen-activated protein kinase activation and c-fos gene expression. Enzyme-linked immunosorbent assay and growth factor-mediated stimulation of proliferation assays in the EGFR-expressing NIH3T3HER14 demonstrated the preferential EGFR-targeting properties of BJ2000, and more importantly suggest that blockade of EGFR phosphorylation by this drug translate into significant growth inhibitory effects. These properties culminated into irreversible antiproliferative effects as confirmed by a sulforhodamine B assay. Five days after a 2-h treatment, BJ2000 retained significant antiproliferative effect in A431 cells, whereas its reversible metabolite FD105 almost completely lost its activity. This result in toto lend support to the Combi-Targeting concept according to which a molecular conjugate kept small enough to interact with EGFR and designed to degrade into another inhibitor of the same target plus a DNA-damaging species may induce sustained growth inhibitory effect in EGFR-overexpressing cells. 相似文献
998.
Patrício Aguiar Diogo Cruz Rita Ferro Rodrigues Lígia Peixoto Francisco Araújo José Luís Ducla Soares 《Revista portuguesa de cardiologia》2013,32(4):331-335
The association between hypocalcemia and heart failure is rare. There are few reported cases in the literature of this association, which is termed hypocalcemic cardiomyopathy.We report the case of a 61-year-old woman with no relevant medical history, admitted for progressively worsening exertional dyspnea, orthopnea and edema of the lower limbs for a previous month. Physical examination showed diffuse muscle spasms, with no signs of latent tetany.Further investigation revealed ionized calcium 0.54 mmol/l (normal 1.12-1.30), phosphorus 9.8 mg/dl, parathyroid hormone <2.5 pg/ml and CK >3000 U/l, with normal thyroid function. The electrocardiogram showed long QT interval and a pattern of left ventricular overload, and myocardial biomarkers were negative. The echocardiogram revealed regional wall motion abnormalities, coronary angiography was normal and a cranial CT scan detected calcification of basal ganglia and white matter.She started diuretic and calcium replacement therapy which resulted in complete clinical recovery, with no need for heart failure therapy after normalization of serum calcium. 相似文献
999.
Ana Arias Yoon H. LeeChristine I. Peters DMD Alan H. GluskinOve A. Peters DMD MS PhD 《Journal of endodontics》2014